Skip to main content
Unknown status

Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma

By April 24, 2017No Comments

Condition

Malignant Mesothelioma

Estimated Enrollment: null

Age Group: Child, Adult, Senior

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: CDR0000068049|LSUMC-3591|NCI-V00-1604

Study First Received: September 11, 2000

Last Updated: September 19, 2013

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

Sponsors and Collaborators:

Louisiana State University Health Sciences Center in New Orleans|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00006216

Leave a Reply